Restore Health pharmacist develops allergy-relieving toothpaste
MADISON, Wis. — Shara Rudner, director, clinical trials group for Restore Health, was part of a research collaboration that developed a new delivery system that could help millions of people who suffer from seasonal allergies.
William Reisacher from Weill Cornell Medical College and research colleagues teamed up with Rudner to study a novel method of delivering allergenic extracts using a compounded toothpaste vehicle. Research results were featured in the July/August 2014 International Journal of Pharmaceutical Compounding.
"We know that 20% to 40% of the U.S. population suffers from allergic rhinitis," Rudner said. "It is important for people living with allergies to work with their physician to develop an appropriate allergy treatment plan that will effectively reduce their symptoms. This research shows that using a toothpaste delivery system to treat patients with allergic rhinitis is very promising."
"This new delivery system for millions who suffer from AR could give physicians another tool to help their patients find relief and help the millions of people who suffer from seasonal allergies," said Matt Wanderer, CEO of Restore Health.
"An important part of Shara's contribution to Restore is the forward-looking research and development of innovative approaches to patient care, including novel drug delivery systems such as toothpaste for agents of immunotherapy," said Murray Firestone, president of Restore Health. "It's truly creative to use an activity in which patients already engage, brushing their teeth, to support adherence with their drug regimen; the definition of a disruptive technology. Kudos to her and her research colleagues."
Reisacher holds equity in Allovate, the company that developed a toothpaste vehicle for immunotherapy delivery, and additionally serves as an unpaid consultant to the company.
AmerisourceBergen awards specialty pharmacy Burmans with ‘Shaping Healthcare Delivery’ honor
BROOKHAVEN, Pa. — Specialty pharmacy Burmans last week announced that it had received the new “Shaping Healthcare Delivery” award at this year’s AmerisourceBergen’s ThinkLive Conference.
Burmans was selected as the first-ever “Shaping Healthcare Delivery” award recipient for enhancing access to treatment for hepatitis C patients through an innovative partnership with AmerisourceBergen. In addition to providing improved access to medication, Burmans’ clinical pharmacists, pharmacy technicians, nurses and disease-specific customer service representatives provide ongoing, individualized care to patients and healthcare providers.
“We are honored that AmerisourceBergen has selected us as the first 'Shaping Healthcare Delivery' award winner. They have been a critical partner in our effort to better treatment access to this patient population,” said Steve Burman, president and CEO, Burmans. “Our hepatitis C specialized pharmacy services were specifically designed with a patient-first approach with the goal of supporting patients and physicians throughout the treatment process, while working toward improving outcomes.”
Burmans has also tailored clinical treatment programs for Hemophilia, Multiple Sclerosis, GH deficiency, oncology-related conditions, and all other major complex disease states.
Goldman Sachs recognizes UrgentRx founder and CEO as one of the ‘100 Most Intriguing Entrepreneurs of 2014’
DENVER — Goldman Sachs is recognizing entrepreneur and UrgentRx founder and CEO Jordan Eisenberg as one of the 100 Most Intriguing Entrepreneurs of 2014 at its Builders + Innovators Summit in Santa Barbara, Calif., UrgentRx announced Wednesday. Goldman Sachs selected Eisenberg as one of 100 entrepreneurs from multiple industries to be honored at the two-day event.
"I am honored to be included among such a talented and diverse group of entrepreneurs," Eisenberg said. "At UrgentRx, we’re committed to bringing new and exciting products to market that help consumers feel better fast. UrgentRx continues to disrupt the OTC medication category through innovative products and impactful consumer marketing. It’s great to be recognized for all of our hard work.”
Prior to founding UrgentRx, Eisenberg launched the Buddy Network, a consumer mobile app business that launched a top iPhone app. In addition, Eisenberg built and sold a successful promotional product business based on products he invented and patented (including the CollarCard and BottleCard). He has also invented and licensed a medical device to a major manufacturer. Previously, Eisenberg worked alongside serial entrepreneur Maurice Kanbar (founder of Skyy Vodka), where he was instrumental in the production and launch of several consumer product businesses.
"We are honored to recognize Jordan as one of the most intriguing entrepreneurs of 2014," stated David Solomon, co-head of investment banking at Goldman Sachs. "This is the third year for the summit and our goal remains the same. We pair seasoned and emerging entrepreneurs – the builders and innovators – from a diverse set of industries to discuss how to make vital, enduring companies that reshape industries and boost the world's economies through innovation."
UrgentRx produces a line of fast-acting, portable over-the-counter medications that provide "Right Now Relief" for today’s busy, on-the-go consumer. UrgentRx Fast Powders are available in single-dose packets and, recently launched, 10-count boxes. The products are intended to treat a variety of common ailments including Headache Relief to Go, Heartburn Relief to Go, Upset Stomach Relief to Go, Ache & Pain Relief to Go, Allergy Attack Relief to Go and Critical Care Aspirin. UrgentRx Fast Powders don’t require water and use proven and effective active ingredients that provide fast-acting relief. The line is sold in over 20,000 locations nationwide.
Loading Post Please Wait...